Immunic
+$0.68 (+5.44%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Immunic and other stocks, options, and ETFs commission-free!
About IMUX
Immunic, Inc. Common Stock, also called Immunic, is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases.
CEO
Daniel Vitt
Employees
28
Headquarters
New York, New York
Founded
2003
IMUX Key Statistics
Market Cap
284.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
173.79K
High Today
$13.50
Low Today
$12.30
Open Price
$12.45
Volume
146.20K
52 Week High
$28.21
52 Week Low
$9.00
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
IMUX Earnings
-$1.63
-$1.09
-$0.54
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.71 per share
Actual
-$1.63 per share